Matthew P M Graham-Brown
Overview
Explore the profile of Matthew P M Graham-Brown including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
589
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ng K, Macdonald J, Young R, March D, Graham-Brown M, Mercer T, et al.
J Cachexia Sarcopenia Muscle
. 2025 Mar;
16(2):e13748.
PMID: 40026059
Background: Haemodialysis patients are at high risk of myopenic obesity, necessitating effective nutritional status monitoring and intervention strategies. This combined analysis of two clinical trials (PEDAL trial and CYCLE-HD study)...
2.
Billany R, Macdonald J, Burns S, Chowdhury R, Ford E, Mubaarak Z, et al.
PLoS One
. 2025 Feb;
20(2):e0316031.
PMID: 39992959
Background: Cardiometabolic diseases are a major cause of morbidity and mortality in kidney transplant recipients (KTR) due to clustering of traditional and non-traditional risk factors including poor physical fitness and...
3.
Graham-Brown M, Burton J, Major R
Br J Cardiol
. 2025 Feb;
31(3):027.
PMID: 39917563
"In spite of the accumulating evidence of their efficacy, established treatments for maintaining renal function remain woefully underutilized. Clinicians and health care systems must be encouraged to make use of...
4.
Greenwood S, Briggs J, Walklin C, Mangahis E, Young H, Castle E, et al.
Kidney Int Rep
. 2024 Nov;
9(11):3204-3217.
PMID: 39534205
Introduction: There is inequity in the provision of physical rehabilitation services for people living with chronic kidney disease (CKD). The Kidney BEAM trial evaluated the clinical value and cost effectiveness...
5.
Lightfoot C, Wilkinson T, Sohansoha G, Gillies C, Vadaszy N, Ford E, et al.
NPJ Digit Med
. 2024 Nov;
7(1):318.
PMID: 39533053
My Kidneys & Me (MK&M), a digital health intervention delivering specialist health and lifestyle education for people with CKD, was developed and its effects tested (SMILE-K trial, ISRCTN18314195, 18/12/2020). 420...
6.
Billany R, Smith A, Graham-Brown M
Nephrol Dial Transplant
. 2024 Nov;
PMID: 39508335
Clustering of traditional and kidney-specific risk factors leads to elevated cardiovascular disease (CVD) risk across the trajectory of chronic kidney disease (CKD) and transplantation. As kidney function declines, the prevalence...
7.
Dattani A, Yeo J, Brady E, Cowley A, Marsh A, Sian M, et al.
J Cardiovasc Magn Reson
. 2024 Oct;
26(2):101120.
PMID: 39477154
Background: Type 2 diabetes (T2D) leads to cardiovascular remodeling, and heart failure has emerged as a major complication of T2D. There is a limited understanding of the impact of T2D...
8.
Hull K, Abell L, Adenwalla S, Billany R, Burns S, Burton J, et al.
Clin Kidney J
. 2024 Jul;
17(7):sfae198.
PMID: 39050864
Background: The haemodialysis (HD) population is sedentary, with substantial cardiovascular disease risk. In the general population, small increases in daily step count associate with significant reductions in cardiovascular mortality. This...
9.
Ayton S, Yeo J, Gulsin G, Dattani A, Bilak J, Deshpande A, et al.
Eur J Radiol
. 2024 Mar;
174:111400.
PMID: 38458143
Background: Dysregulated epicardial adipose tissue (EAT) may contribute to the development of heart failure in Type 2 diabetes (T2D). This study aimed to evaluate the associations between EAT volume and...
10.
Lightfoot C, Wilkinson T, Vadaszy N, Graham-Brown M, Davies M, Yates T, et al.
J Ren Care
. 2024 Jan;
50(3):283-296.
PMID: 38296833
Background: Self-management is a key component of successful chronic kidney disease (CKD) management. Here, we present the findings from the internal pilot of a multicentre randomised controlled trial (RCT) aimed...